Overview
Peter Incze practices practicing medicine in Toronto, Canada.
Mr. Incze is highly rated in 1 condition, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH) and Prostate Cancer.
He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 3 clinical trials.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Frequently Asked Questions about Peter F. Incze
Is Peter F. Incze a top-rated expert for Enlarged Prostate (BPH)?
MediFind is an objective health platform that identifies experts based on real-world data. Peter F. Incze is classified as an Advanced expert for Enlarged Prostate (BPH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Peter F. Incze participate in research or clinical trials?
Yes. Peter F. Incze has published 12 articles and abstracts on conditions like Enlarged Prostate (BPH). You can view a list of Peter F. Incze's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Enlarged Prostate (BPH)Mr. Incze isAdvanced. Learn about Enlarged Prostate (BPH).
- Experienced
- Prostate CancerMr. Incze isExperienced. Learn about Prostate Cancer.